RISK BASED INSPECTION [WHO TRS 986-POINT (10.1-10.5)]
![RISK BASED INSPECTION [WHO TRS 986-POINT (10.1-10.5)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-10.1-10.5-1-768x1087.jpg)
In WHO TRS 986 (Annex 2), 10.1–10.5 define the GMP training system inspectors expect to see working in practice—not just a “training file”. Under a risk-based inspection (RBI), regulators prioritize inspection depth and sampling based on public-health risk and compliance…





![RISK BASED INSPECTION [SCHEDULE M-POINT (9.10-9.13)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-9.10-9.13-1-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (9.7-9.9)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-WHO-TRS-986-9.7-9.9-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (9.1-9.6)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-WHO-TRS-986-9.1-9.6-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.33-8.35)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.33-8.35-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (8.29-8.32)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-WHO-TRS-986-8.29-8.32-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (8.25-8.28)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-WHO-TRS-986-8.25-8.28-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.21-8.24)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.21-8.24-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.18-8.20)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.18-8.20-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (8.16-8.17)]](https://pharmadevils.com/wp-content/uploads/2024/10/Schedule-M-8.16-8.17-768x1086.jpg)